Chito-Oligosaccharide Inhibits the De-Methylation of a 'CpG' Island within the Leptin (LEP) Promoter during Adipogenesis of 3T3-L1 Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bahar, Bojlul ^a   O'Doherty, John V ^a   O'Doherty, Alan M ^a   Sweeney, Torres ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSE OLIGOSACCHARIDE; LEPTIN; MESSENGER RNA; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN 3T3; CONTROLLED STUDY; CPG ISLAND; CPG ISLAND 52; CPG ISLAND 62; CPG ISLAND 95; DEMETHYLATION; DNA STRUCTURE; DOWN REGULATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; LEPTIN GENE; MOUSE; NONHUMAN; PROADIPOCYTE; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN SECRETION;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CHITOSAN; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; LEPTIN; MICE; OLIGOSACCHARIDES; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84875462347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060011     Document Type: Article

References (46)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR, (2010) Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 303: 235-241.
2. Malik VS, Willett WC, Hu FB, (2013) Global obesity: trends, risk factors and poly implications. Nat. Rev. Endocrinol. 9: 13-27 doi:10.1038/nrendo.2012.199.
3. Attie AD, Scherer PE, (2009) Adipocyte metabolism and obesity. J. Lipid Res. 50: S395-S399.
4. Despres JP, Lemieux I, (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
5. Meijer K, de Vries M, Al-Lahham S, Bruinenberg M, Weening D, et al. (2011) Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS ONE 6: e17154.
6. Gregoire FM, Smas CM, Sul HS, (1998) Understanding adipocyte differentiation. Physiol. Rev (78) (): 783-809.
7. Green H, Kehinde O, (1975) An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell 5: 19-27.
8. Ntambi JM, Young-Cheul K, (2000) Adipocyte Differentiation and Gene Expression. J. Nutr. 130(12): 3122S-3126S.
9. Dave S, Kaur NJ, Nanduri R, Dkhar HK, Kumar A, et al. (2012) Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes. PLoS ONE 7: e30831.
10. Ejaz A, Wu D, Kwan P, Meydani M, (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/Bl mice. J. Nutr. 139: 919-925.
11. Cho EJ, Kim SW, Hwang HJ, Hwang HS, Yun JW, (2008) Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J. Microbiol. 18: 80-87.
12. Kim KJ, Lee OH, Lee BY, (2010) Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Sci. 86: 791-797.
13. Kim KJ, Lee BY, (2012) Fucoidan from the sporophyll of Undaria pinnatifida suppresses adipocyte differentiation by inhibition of inflammation-related cytokines in 3T3-L1 cells. Nutr. Res. 32: 439-447.
14. Arney KL, Fisher AG, (2004) Epigenetic aspects of differentiation. J. Cell Sci. 117: 4355.
15. Guo W, Zhang KM, Tu K, Li YX, Zhu L, et al. (2009) Adipogenesis licensing and execution are disparately linked to cell proliferation. Cell Res. 19: 216-223.
16. Melzner I, Scott V, Dorsch K, Fischer P, Wabitsch M, et al. (2002) Leptin gene expression in human preadipocytes is switched on by maturation-induced de-methylation of distinct CpGs in its proximal promoter. J. Biol. Chem. 277: 45420-45427.
17. Yokomori N, Tawata M, Onaya T, (2002) DNA demethylation modulates mouse leptin promoter activity during the differentiation of 3T3-L1 cells. Diabetologia 45: 140-148.
18. Hwang CS, Loftus TM, Mandrup S, Lane MD, (1997) Adipocyte differentiation and leptin expression. Annu. Rev. Cell Dev. Bi. 13: 231-259.
19. Bahar B, O'Doherty JV, Sweeney T, (2011) A potential role of IL-6 in the chito-oligosaccharide-mediated inhibition of adipogenesis. Br. J. Nutr. 106: 1142-1153.
20. Reidy SP, Weber JM, (2000) Leptin: an essential regulator of lipid metabolism. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 125: 285-298.
21. Zhang P, Klenk ES, Lazzaro MA, Williams LB, Considine RV, (2002) Hexosamines regulate leptin production in 3T3-L1 adipocytes through transcriptional mechanisms. J. Endocrinol. 143: 99-106.
22. Walsh AM, Sweeney T, Bahar B, O'Doherty JV, (2013) Multi-functional roles of chitosan as a potential protective agent against obesity. PLoS ONE. 8: e53828.
23. O'Doherty AM, Rutledge CE, Sato S, Thakur A, Lees-Murdock DJ, et al. (2011) DNA methylation plays an important role in promoter choice and protein production at the mouse Dnmt3L locus. Dev. Biol. 356: 411-420.
24. Hwang CS, Mandrup S, MacDougald OA, Geiman DE, Lane MD, (1996) Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Proc. Natl. Acad. Sci. 93: 873-877.
25. Li H, Xiao L, Wang C, Gao J, Zhai Y, (2010) Epigenetic regulation of adipocyte differentiation and adipogenesis. J. Zhejiang Univ. Sci. B 11: 784-791.
26. Salma N, Xiao H, Imbalzano AN, (2006) Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo. J. Mol. Endocrinol. 36: 139-151.
27. Kim WK, Lee CY, Kang MS, Kim MH, Ryu YH, et al. (2008) Effects of leptin on lipid metabolism and gene expression of differentiation-associated growth factors and transcription factors during differentiation and maturation of 3T3-L1 preadipocytes. Endocr. J. 55: 827-837.
28. Lee YH, Chen SY, Wiesner RJ, Huang YF, (2004) Simple flow cytometric method used to assess lipid accumulation in fat cells. J. Lipid Res. 45: 1162-1167.
29. Moskalev EA, Zavgorodnij MG, Majorova SP, Vorobjev IA, Jandaghi P, et al. (2011) Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression. Nucleic Acids Res. 39: e77.
30. Hsieh CL, (1994) Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14: 5487-5494.
31. Farooqi IS, O'Rahilly S, (2009) Leptin: a pivotal regulator of human energy homeostasis. Am. J. Clin. Nutr. 89: 980S-984S.
32. Enriori PJ, Evans AE, Sinnayah P, Cowley MA, (2006) Leptin resistance and obesity. Obesity 14: 254S-258S.
33. Marroquã L, Gonzalez A, Ã'eco P, Caballero-Garrido E, Vieira E, et al. (2012) Role of leptin in the pancreatic Î2-cell: effects and signaling pathways. J. Mol. Endocrinol. 49: R9-R17.
34. Cases JA, Gabriely I, Ma XH, Yang XM, Michaeli T, et al. (2001) Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 50: 348-352.
35. Covey SD, Wideman RD, McDonald C, Unniappan S, Huynh F, et al. (2006) The pancreatic Î2 cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab. 4: 291-302.
36. Lee HW, Park YS, Choi JW, Yi SY, Shin WS, (2003) Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol. Pharm. Bull. 26: 1100-1103.
37. Liu SH, Chang YH, Chiang MT, (2010) Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. J. Agr. Food Chem. 58: 5795-5800.
38. Gregoire FM, Smas CM, Sul HS, (1998) Understanding adipocyte differentiation. Physiol. Rev. 78: 783-809.
39. Tilg H, Moschen AR, (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6: 772-783.
40. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, et al. (1997) Crystal structure of the obese protein Ieptin-E100. Nature 387: 206-209.
41. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, et al. (1998) Leptin regulates proinflammatory immune responses. FASEB J. 12: 57-65.
42. Matarese G, Moschos S, Mantzoros CS, (2005) Leptin in immunology. J. Immunol. 174: 3137-3142.
43. Kallen CB, Lazar MA, (1996) Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. 93: 5793-5796.
44. Nishio K Meiei S, Kodama Y, Itoh S, Konno N, et al. (2008) The effect of pioglitazone on nitric oxide synthase in patients with type 2 diabetes mellitus. J. Cardiometab. Syndr. 3: 200-204.
45. Wu J, Lei MX, Chen HL, Sun ZX, (2004) Effects of rosiglitazone on serum leptin and insulin resistance in patients with Type 2 diabetes. J. Central South University 29: 623-626.
46. Koh KK, Park SM, Quon MJ, (2008) Leptin and cardiovascular disease. Circulation 117: 3238-3249.